Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: TRITERPENOID THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-16 to 2024-03-15
Current total value of award: $400000
Description: TOPIC 430: A NEW SMALL MOLECULE SENOTHERAPEUTIC FOR THE CHEMOPREVENTION OF THERAPY-RELATED COGNITIVE AGING